GMCL1
gene geneOn this page
Also known as FLJ13057BTBD13GCL1SPATA29
Summary
GMCL1 (germ cell-less 1, spermatogenesis associated, HGNC:23843) is a protein-coding gene on chromosome 2p13.3, encoding Germ cell-less protein-like 1 (Q96IK5). Possible function in spermatogenesis.
This gene encodes a nuclear envelope protein that appears to be involved in spermatogenesis, either directly or by influencing genes that play a more direct role in the process. This multi-exon locus is the homolog of the mouse and drosophila germ cell-less gene but the human genome also contains a single-exon locus on chromosome 5 that contains an open reading frame capable of encoding a highly-related protein.
Source: NCBI Gene 64395 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 66 total
- MANE Select transcript:
NM_178439
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23843 |
| Approved symbol | GMCL1 |
| Name | germ cell-less 1, spermatogenesis associated |
| Location | 2p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ13057, BTBD13, GCL1, SPATA29 |
| Ensembl gene | ENSG00000087338 |
| Ensembl biotype | protein_coding |
| OMIM | 618627 |
| Entrez | 64395 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 7 protein_coding, 2 protein_coding_CDS_not_defined, 1 retained_intron
ENST00000282570, ENST00000468386, ENST00000471404, ENST00000495047, ENST00000885038, ENST00000885039, ENST00000885040, ENST00000885041, ENST00000916919, ENST00000947258
RefSeq mRNA: 1 — MANE Select: NM_178439
NM_178439
CCDS: CCDS1895
Canonical transcript exons
ENST00000282570 — 14 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000759462 | 69854823 | 69854960 |
| ENSE00000759465 | 69864900 | 69864975 |
| ENSE00000846463 | 69840942 | 69841039 |
| ENSE00000846464 | 69843149 | 69843261 |
| ENSE00000846469 | 69861278 | 69861347 |
| ENSE00000846471 | 69869719 | 69869864 |
| ENSE00001006481 | 69878909 | 69881384 |
| ENSE00001847160 | 69829660 | 69830152 |
| ENSE00003462378 | 69844131 | 69844196 |
| ENSE00003505301 | 69847543 | 69847627 |
| ENSE00003516750 | 69871745 | 69871832 |
| ENSE00003516752 | 69849652 | 69849742 |
| ENSE00003605490 | 69839457 | 69839553 |
| ENSE00003687792 | 69837547 | 69837670 |
Expression profiles
Bgee: expression breadth ubiquitous, 261 present calls, max score 91.68.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 13.8281 / max 210.8419, expressed in 1778 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 20773 | 13.5120 | 1775 |
| 20774 | 0.2135 | 80 |
| 20775 | 0.1027 | 28 |
Top tissues by expression
281 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 91.68 | gold quality |
| oocyte | CL:0000023 | 91.15 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.01 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.80 | gold quality |
| calcaneal tendon | UBERON:0003701 | 85.42 | gold quality |
| adult organism | UBERON:0007023 | 85.39 | gold quality |
| rectum | UBERON:0001052 | 84.99 | gold quality |
| monocyte | CL:0000576 | 84.81 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.74 | gold quality |
| leukocyte | CL:0000738 | 84.72 | gold quality |
| mononuclear cell | CL:0000842 | 84.66 | gold quality |
| duodenum | UBERON:0002114 | 84.65 | gold quality |
| choroid plexus epithelium | UBERON:0003911 | 84.13 | gold quality |
| jejunal mucosa | UBERON:0000399 | 83.88 | gold quality |
| ganglionic eminence | UBERON:0004023 | 83.40 | gold quality |
| bone marrow | UBERON:0002371 | 83.39 | gold quality |
| testis | UBERON:0000473 | 83.30 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 82.87 | gold quality |
| popliteal artery | UBERON:0002250 | 82.85 | gold quality |
| tibial artery | UBERON:0007610 | 82.85 | gold quality |
| ventricular zone | UBERON:0003053 | 82.82 | gold quality |
| left testis | UBERON:0004533 | 82.81 | gold quality |
| right testis | UBERON:0004534 | 82.56 | gold quality |
| artery | UBERON:0001637 | 82.38 | gold quality |
| bone marrow cell | CL:0002092 | 82.15 | gold quality |
| pancreas | UBERON:0001264 | 82.10 | gold quality |
| body of pancreas | UBERON:0001150 | 81.89 | gold quality |
| aorta | UBERON:0000947 | 81.50 | gold quality |
| bronchial epithelial cell | CL:0002328 | 81.48 | gold quality |
| gall bladder | UBERON:0002110 | 81.48 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.87 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
170 targeting GMCL1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-LET-7A-3P | 100.00 | 74.03 | 3932 |
| HSA-LET-7B-3P | 100.00 | 74.08 | 3913 |
| HSA-LET-7F-1-3P | 100.00 | 74.02 | 3928 |
| HSA-MIR-98-3P | 100.00 | 74.08 | 3907 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-1185-1-3P | 99.98 | 71.04 | 2593 |
| HSA-MIR-1185-2-3P | 99.98 | 71.04 | 2593 |
| HSA-LET-7F-2-3P | 99.98 | 70.98 | 2588 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-302E | 99.96 | 70.74 | 2669 |
| HSA-MIR-548AJ-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548X-3P | 99.96 | 73.38 | 5345 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-4267 | 99.96 | 66.53 | 2368 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-9-3P | 99.96 | 70.88 | 2068 |
| HSA-MIR-548J-3P | 99.94 | 72.61 | 4881 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-6744-5P | 99.93 | 66.82 | 748 |
Literature-anchored findings (GeneRIF, showing 5)
- GCL binds directly to emerin, and the emerin-repressor complexes might be regulated by barrier to autointegration factor (PMID:12493765)
- mGCL-1 is a factor modulating MDM2-p53 axis by enhanced degradation of MDM2 (PMID:12927808)
- Germ cell-less protein is not essential for the chromosomal events of meiosis but might be involved in later aspects of spermatogenesis. (PMID:12954656)
- Dual association of GAGE family members with GCL at the nuclear envelope inner membrane in cells, and with dsDNA in vitro, implicate GAGE proteins in chromatin regulation in germ cells and cancer cells. (PMID:23029259)
- Mouse GMCL1 interacts with the DP component of the E2F transcription factor. (PMID:9878064)
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | gmcl1 | ENSDARG00000020948 |
| mus_musculus | Gmcl1 | ENSMUSG00000001157 |
| rattus_norvegicus | Gmcl1 | ENSRNOG00000017838 |
| drosophila_melanogaster | gcl | FBGN0005695 |
| caenorhabditis_elegans | WBGENE00013382 |
Paralogs (3): BTBD16 (ENSG00000138152), C10orf120 (ENSG00000183559), GMCL2 (ENSG00000244234)
Protein
Protein identifiers
Germ cell-less protein-like 1 — Q96IK5 (reviewed: Q96IK5)
Alternative names: Spermatogenesis-associated protein 29
All UniProt accessions (2): Q96IK5, Q53SE7
UniProt curated annotations — full annotation on UniProt →
Function. Possible function in spermatogenesis. Enhances the degradation of MDM2 and increases the amount of p53 probably by modulating the nucleocytoplasmic transport.
Subunit / interactions. Interacts with TMPO-beta, TSG101 and TFDP2. Interacts with EMD.
Subcellular location. Nucleus matrix.
RefSeq proteins (1): NP_848526* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000210 | BTB/POZ_dom | Domain |
| IPR011333 | SKP1/BTB/POZ_sf | Homologous_superfamily |
| IPR011705 | BACK | Domain |
| IPR043380 | Gcl-like | Family |
Pfam: PF00651, PF07707
UniProt features (15 total): sequence conflict 5, region of interest 2, short sequence motif 2, compositionally biased region 2, modified residue 2, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q96IK5-F1 | 84.82 | 0.74 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 66, 68
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 138 (showing top):
PEREZ_TP63_TARGETS, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_MALE_GAMETE_GENERATION, PATIL_LIVER_CANCER, MODULE_171, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, PEREZ_TP53_AND_TP63_TARGETS, GOBP_DEVELOPMENTAL_PROCESS_INVOLVED_IN_REPRODUCTION, LIU_CMYB_TARGETS_UP, LIU_VMYB_TARGETS_UP, SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_DN, MILI_PSEUDOPODIA_CHEMOTAXIS_DN, MATZUK_SPERMATOZOA, STEIN_ESRRA_TARGETS_UP, chr2p13
GO Biological Process (3): germ cell development (GO:0007281), spermatogenesis (GO:0007283), cell differentiation (GO:0030154)
GO Molecular Function (2): identical protein binding (GO:0042802), protein binding (GO:0005515)
GO Cellular Component (2): nucleus (GO:0005634), nuclear matrix (GO:0016363)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| developmental process involved in reproduction | 2 |
| gamete generation | 1 |
| cellular process involved in reproduction in multicellular organism | 1 |
| cell development | 1 |
| male gamete generation | 1 |
| cellular developmental process | 1 |
| protein binding | 1 |
| binding | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
804 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| GMCL1 | USHBP1 | Q8N6Y0 | 510 |
| GMCL1 | SPIN4 | Q56A73 | 506 |
| GMCL1 | ZBTB25 | P24278 | 407 |
| GMCL1 | ADAM20 | O43506 | 402 |
| GMCL1 | NTMT2 | Q5VVY1 | 388 |
| GMCL1 | FAM13B | Q9NYF5 | 387 |
| GMCL1 | FAM98C | Q17RN3 | 372 |
| GMCL1 | SPATA6 | Q9NWH7 | 362 |
| GMCL1 | PGAM1 | P18669 | 353 |
| GMCL1 | PGAM4 | Q8N0Y7 | 353 |
| GMCL1 | PRR14 | Q9BWN1 | 352 |
| GMCL1 | KIF4B | Q2VIQ3 | 340 |
| GMCL1 | SPATA1 | Q5VX52 | 338 |
| GMCL1 | STYXL1 | Q9Y6J8 | 328 |
| GMCL1 | H0YHX9 | H0YHX9 | 324 |
IntAct
367 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| GMCL1 | FAM167A | psi-mi:“MI:0915”(physical association) | 0.800 |
| GMCL1 | XAGE3 | psi-mi:“MI:0915”(physical association) | 0.800 |
| XAGE3 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.800 |
| FAM167A | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.800 |
| MID1 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.780 |
| CUL3 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.740 |
| GMCL1 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| PAX4 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.720 |
| BYSL | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| KAT5 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| QRICH1 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.700 |
| GMCL1 | BYSL | psi-mi:“MI:0915”(physical association) | 0.700 |
| CCKBR | PRKAG1 | psi-mi:“MI:0914”(association) | 0.640 |
| GMCL1 | ADY3 | psi-mi:“MI:0915”(physical association) | 0.610 |
| GMCL1 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| GMCL1 | MAS1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SUI2 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| REC107 | GMCL1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GMCL1 | ASP1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (279): GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid), GMCL1 (Two-hybrid)
ESM2 similar proteins: A4FUF0, A5HK05, B0K012, O43324, O43929, O75431, O94955, O95453, P20135, P42694, P47802, P69341, P70102, P78417, Q2L969, Q3U2J5, Q3UFS0, Q49A26, Q4R8V9, Q562D5, Q5R6Z7, Q5R7T2, Q5RC51, Q5RDU9, Q5RKH0, Q5ZIA0, Q5ZLS2, Q5ZLS7, Q6AXV9, Q6DC64, Q6DFV5, Q6GR37, Q6NYU2, Q7SXV1, Q7Z624, Q8IX04, Q8K2D3, Q8K2Q2, Q8R5L3, Q8VE33
Diamond homologs: Q01820, Q8NEA9, Q920G9, Q96IK5, Q99N64, Q6NRS1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
66 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 47 |
| Likely benign | 1 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1968 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 2:69830151:AGG:A | donor_loss | 1.0000 |
| 2:69830152:GGTA:G | donor_loss | 1.0000 |
| 2:69830153:G:C | donor_loss | 1.0000 |
| 2:69837666:GTCAA:G | donor_gain | 1.0000 |
| 2:69837667:TCAAG:T | donor_loss | 1.0000 |
| 2:69837668:CAAG:C | donor_loss | 1.0000 |
| 2:69837669:AAGTA:A | donor_loss | 1.0000 |
| 2:69837670:AG:A | donor_loss | 1.0000 |
| 2:69837671:G:C | donor_loss | 1.0000 |
| 2:69837671:G:GG | donor_gain | 1.0000 |
| 2:69837672:TAA:T | donor_loss | 1.0000 |
| 2:69839454:A:AG | acceptor_gain | 1.0000 |
| 2:69839455:A:G | acceptor_gain | 1.0000 |
| 2:69839455:AGTCT:A | acceptor_gain | 1.0000 |
| 2:69839456:G:GA | acceptor_gain | 1.0000 |
| 2:69839456:GT:G | acceptor_gain | 1.0000 |
| 2:69839456:GTCT:G | acceptor_gain | 1.0000 |
| 2:69839456:GTCTG:G | acceptor_gain | 1.0000 |
| 2:69839472:A:AG | acceptor_gain | 1.0000 |
| 2:69839473:G:GG | acceptor_gain | 1.0000 |
| 2:69839549:AGAAG:A | donor_loss | 1.0000 |
| 2:69839550:GAAGG:G | donor_loss | 1.0000 |
| 2:69839551:AAGGT:A | donor_loss | 1.0000 |
| 2:69839552:AGGTA:A | donor_loss | 1.0000 |
| 2:69839553:GG:G | donor_loss | 1.0000 |
| 2:69839554:G:GA | donor_loss | 1.0000 |
| 2:69839555:T:G | donor_loss | 1.0000 |
| 2:69840924:T:G | acceptor_gain | 1.0000 |
| 2:69840929:ACCTT:A | acceptor_gain | 1.0000 |
| 2:69840933:T:A | acceptor_gain | 1.0000 |
AlphaMissense
3407 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 2:69864950:G:A | G398D | 1.000 |
| 2:69869725:T:A | W409R | 1.000 |
| 2:69869725:T:C | W409R | 1.000 |
| 2:69869731:T:A | W411R | 1.000 |
| 2:69869731:T:C | W411R | 1.000 |
| 2:69869733:G:C | W411C | 1.000 |
| 2:69869733:G:T | W411C | 1.000 |
| 2:69869797:C:A | R433S | 1.000 |
| 2:69837591:T:C | F102S | 0.999 |
| 2:69837650:C:G | H122D | 0.999 |
| 2:69849652:T:A | W282R | 0.999 |
| 2:69849652:T:C | W282R | 0.999 |
| 2:69861307:T:A | W368R | 0.999 |
| 2:69861307:T:C | W368R | 0.999 |
| 2:69864944:G:C | R396T | 0.999 |
| 2:69864944:G:T | R396M | 0.999 |
| 2:69864945:G:C | R396S | 0.999 |
| 2:69864945:G:T | R396S | 0.999 |
| 2:69864954:A:C | R399S | 0.999 |
| 2:69864954:A:T | R399S | 0.999 |
| 2:69869727:G:C | W409C | 0.999 |
| 2:69869727:G:T | W409C | 0.999 |
| 2:69869728:C:A | R410S | 0.999 |
| 2:69869729:G:C | R410P | 0.999 |
| 2:69869732:G:C | W411S | 0.999 |
| 2:69869740:T:C | F414L | 0.999 |
| 2:69869742:T:A | F414L | 0.999 |
| 2:69869742:T:G | F414L | 0.999 |
| 2:69869756:A:C | D419A | 0.999 |
| 2:69869756:A:G | D419G | 0.999 |
dbSNP variants (sampled 300 via entrez): RS1000032898 (2:69858687 C>A,T), RS1000040630 (2:69877040 A>C), RS1000067923 (2:69833439 A>C), RS1000129886 (2:69856451 G>T), RS1000222953 (2:69840115 G>A), RS1000223643 (2:69833344 G>A), RS1000283148 (2:69830281 G>A), RS1000307422 (2:69849320 C>G), RS1000356699 (2:69843251 G>A), RS1000396494 (2:69828132 A>G,T), RS1000396764 (2:69870831 A>G,T), RS1000432472 (2:69877770 T>TA), RS1000530803 (2:69831272 A>G), RS1000565389 (2:69838459 G>C), RS1000595854 (2:69831779 T>C)
Disease associations
OMIM: gene MIM:618627 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST003208_10 | Colorectal or endometrial cancer | 6.000000e-06 |
| GCST004297_2 | Atrial fibrillation | 1.000000e-10 |
| GCST006061_30 | Atrial fibrillation | 1.000000e-17 |
| GCST006414_66 | Atrial fibrillation | 1.000000e-16 |
| GCST009200_21 | Whole brain grey matter density | 2.000000e-06 |
| GCST90002404_20 | Red cell distribution width | 5.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004230 | endometrial neoplasm |
| EFO:0010306 | Grey matter density measurement |
| EFO:0009188 | Red cell distribution width |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| aristolochic acid I | decreases expression | 1 |
| bisphenol A | decreases methylation | 1 |
| arsenite | affects binding, decreases reaction | 1 |
| sodium arsenite | decreases expression | 1 |
| aflatoxin B2 | decreases methylation | 1 |
| beta-methylcholine | affects expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| abrine | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Benzo(a)pyrene | affects methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Thiram | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.